ABSTRACT: Stem cells are basic cells of all multicellular organisms having the potency to differentiate into wide range of adult cells. Self renewal and totipotency are characteristic of stem cells. Though totipotency is shown by very early embryonic stem cells, the adult stem cells possess multipotency and differential plasticity which can be exploited for future generation of therapeutic options.
INTRODUCTION:
Stem cells are primal cells common to all multicellular organisms that retain the ability to renew themselves through cell division and can be differentiated into a wide range of specialized cell types. Modern therapeutics is having a lot of hope from stem cell research in the field of organ transplantation and replacement of lost tissue. By virtue of self renewal and potency, stem cells can form various types of tissue cells. The regulators of stem cell growth at genomic and proteomic level are identified and we might be able to control stem cell in vitro. In developed countries, stem cell transplant has become a therapeutic option but in developing countries, it is still under trial phase. There can be two sources of stem cells -Autologous and Allogenic. Autologous embryonic stem cells generated through therapeutic cloning and highly plastic adult stem cells from the umbilical cord blood or bone marrow are promising candidates. Allogenic stem cells can be derived from marrow, peripheral blood, cord blood, family donors or HLA typed or untyped unrelated donors. This article focuses on types of stem cells and stem cell regulation with enlightening comments on clinical application and future aspects.
HISTORICAL BACKGROUND:
Although the first attempts were made to fertilize mammalian eggs outside the body in 1878, research in human stem cell field grew out of findings by Canadian scientists Ernest A. McCulloch and James E. Till in the 1960s 1, 2 . The first use of bone marrow transplant in the present context to stem cell transplant (SCT) was done by Schretzenmyr in 1937 3 as these stem cells are known to be present in the bone marrow of adults. 4 First animal made by in-vitro fertilization (IVF) in 1959 was also a step towards SCT. In late 1960s, teratocarcinomas were determined to originate from embryonic germ cells in mice and Embryonal Carcinoma (EC) cells were identified as a kind of stem cell. The first human egg was fertilized in vitro in 1968 and raised the possibility of exploitation of totipotency of stem cells. Cultured EC cells were explored as models of embryonic development in mice in 1970s. In 1981, it was proved that mouse Embryonic Stem (ES) cells are derived from the inner cell mass of blastocysts. Mouse ES cells were grown in vitro and ES cells injected into mice which formed teratomas. Between 1984-1988 pluripotent clonal cells called Embryonal Carcinoma (EC) cells were developed. When exposed to retinoic acid these cells differentiated into neuron-like cells and other cell types. A clonal line of human embryonal carcinoma cells was derived that yields tissues from all three primary germ layers in 1989. They had limited replicative and differentiative capacity. In 1994, human blastocysts were generated and the inner cell mass was maintained in culture. Cells like ES cells formed in the center and retained stem cell like morphology. In 1995-96, non-human primate ES cells were maintained in vitro from the inner cell mass of monkeys. These cells were pluripotent and differentiated normally into all three primary germ layers 3 . Embryonic Stem cells (ES) cells from the inner cell mass of normal human blastocysts were cultured and maintained normally for many passages in 1998. In 2000, scientists derived human ES cells from the inner cell mass of blastocysts. They proliferated in vitro for a long time and form all three germ layers and teratomas when injected into immune deficient mice. The onset of 21st century hampered the stem cell research due to changed US funding rules; however the funding from The California Institute for Regenerative Medicine supported the research. Stem cell research became more promising as human ES cell lines were shared and new lines were derived, more research groups were focusing attention on the differentiation of cells in vitro.
WHAT IS STEM CELL?
Stem cells are primal cells which are considered to be progenitor of more than 200 cell types present in adult body. All stem cells are unspecialized (undifferentiated) cells that are characteristically of the same family type (lineage). They retain the ability to divide throughout life and give rise to cells that can become highly specialized and take the place of cells that die or are lost. The rigorous definition of a stem cell requires that it possesses two properties: Self renewal and Unlimited potency. Self renewal means the ability to go through numerous cycles of cell division while maintaining the undifferentiated state. Unlimited potency means the capacity to differentiate into any mature cell type. In a strict sense, this makes stem cells either totipotent or pleuripotent. Multipotent and unipotent are also described to define stem cell potency. These properties can be illustrated in vitro using methods such as clonogenic arrays where the progeny of cells is characterized 5 . Two broad categories of stem cells exist: embryonic stem cells derived from blastocyst and adult stem cells which are found in adult tissue. In a developing embryo, stem cells are able to differentiate into all the specialized embryonic tissue. In adults, stem cells act as a repair system for the body replacing specialized damaged cells.
POTENCY DEFINITIONS:
Potency specifies the differential potential of the stem cells. Totipotent stem cells are produced from the fusion of an egg and a sperm cell. Cells produced by the first few divisions of the fertilized egg are also totipotent. This developmental stage is the blastocyst stage -32 cell stage, from which these pleuripotent cells can be isolated 6 . Pleuripotency of embryonic stem cells: Embryonic stem cells can give rise to cells from all three embryonic germ layers i.e. ectoderm, mesoderm and endoderm, even after being grown in culture for a long time. In other words they can develop into each of more than 220 cell types of the adult body when given the sufficient and necessary stimulation for a specific cell type. ES cells can be maintained in culture as undifferentiated cell lines or induced to differentiate into many different lineages 7 . Pleuripotency distinguishes ES cells from multipotent cells found in adults, which can only form a limited number of different cell types.
Regulation of pleuripotency of ES cells:
Researches at Genomic institute, Singapore in collaboration with colleagues from US, have discovered a gene that plays a crucial role in human embryonic stem cells. Scientists studying on mice identified a gene that encodes a transcripion factor, Sall4, a protein that switches gene on and off. Such transcription factors are crucial for the identity of the cell. Transcription factors also regulate the development of cells from the primitive cell stage to functional cell making up the tissue and entire development from the fertilized egg to grown individuals. There are various proteins described which regulate the pleuripotency of ES cells. Some of these are:
Oct 4 protein: It has been used as a key marker for ES cells and for the pleuripotent cells of the intact embryo. Its expression must be maintained at a critical level for ES cells to remain undifferentiated. Nanong protein: It is essential for maintenance of the undifferentiated state of the mouse cells. The expression of Nanong decreased rapidly as mouse ES cells differentiated and when its expression level was maintained by a constitutive promoter, mouse ES cells could remain undifferentiated and proliferate in the absence of either LIF or BMP in serum free medium. Nanong is also expressed in human ES cells, though at a much lower level compared to that of Oct4 and its function in human ES cells was yet to be examined. Recent studies also implicate the Wnt-β-catenin signaling in maintaining pleuripotency 8 . Adult Stem Cells: Adult stem cells are undifferentiated cells found through out the body that divide to replenish dying cells and regenerate damaged tissue. They are also known as somatic stem cells which can be found in children as well as adults. Properties: The rigorous definition of stem cell require that it possesses two properties: Self renewal-the ability to go through numerous cycles of cell division while maintaining the undifferentiated state and Multipotency-the ability to generate progeny of several distinct cell type e.g. both glial cells and neurons, opposed to unipotency restriction to a single cell type. To ensure self renewal, stem cell undergoes two types of cell division: symmetric division give rise to two identical daughter cells both endured with stem cell properties and asymmetric division which produces only one stem cell and a progenitor cell with limited self renewal potential. Progenitor can go through several round of cell division before terminally differentiating into a mature cell. It is believed that molecular distinction between symmetric and asymmetric division lies in differential segregation of cell membrane proteins (such as receptors) between the daughter cells. Regulation of differentiations of Adult Stem Cells: Adult stem cell researches have been focused on uncovering the general molecule mechanism that control their self renewal and differentiation.
Bmi-1: The transcriptional repressor Bmi-1 is one of the polycamb-group proteins, which was discovered as a common oncogene activated in lymphoma 9 and later shown to specially regulate hemato-poietic stem cells 10 . The role of Bmi-1 has also been illustrated in neural stem cells 9 . Notch: The Notch pathway has been known to developmental biologists for decades. Its role in control of stem cell proliferation has now been demonstrated for several cell types including hematopoietic, neural and mammary stem cells 11 . Sonic hedgehog and Wnt: These developmental pathways are also strongly implicated as stem cell regulators 12 . Plasticity: A change in stem cell differentiation from one cell types to another is called trans differentiation, and the multiplicity of stem cell differentiation options is known as developmental plasticity 13, 14 for example, new drugs are not generally tested on human heart cells because no human heart cell lines exist. Instead researchers rely on animal models. Because of important species specific differences between animal and human heart, however, drugs that are toxic to the human heart have occasionally entered clinical trials, sometimes resulting in death. Human ES cells -derived heart cells may be extremely valuable in identifying such drugs before they are used in clinical trials, there by accelerating the drug discovery process and leading to safer and more effective treatments 32,33,34 . 4. Cell based therapies: It is perhaps the most important potential application of human stem cells. They generate cells and tissues that could be used for cells based therapies. Stem cells, directed to differentiate into specific cell types, offer the possibility of a renewable source of replacement cells and tissues to treat various disease. 5. Brain Damage 8, 35, 36 : In the case of brain injury although reparative process appears to initiate, substantial recovery is rarely observed in adults suggesting a lack of robustness.
Recently from research conducted in rats subjected to stroke suggested that administration of drugs to increase the stem cell division rate and direct the survival and differentiation of newly formed cells could be successful.
Cancer: Researcher at Harvard Medical
School caused intracranial tumor in rodents. Then they injected human neural stem cells. Within days the cells had migrated into the cancerous and produced cytosine deaminase, an enzyme that convents a non-toxic prodrug into a chemotherapeutic agent. As a result, the injected substance was able to reduce tumor mass by 80 percent Stem cell research is a minefield of ethical problems because stem cells that offer the most potential for study must be harvested from human embryos that are a few days old. In 1996, the birth of Dolly the sheep --the world's first successfully cloned mammal --ignited a firestorm of protest and concern. The most famous controversy in stem cell research has been Hwang's claim of cloning a dog. Hwang's work was able to offer an alternative to use of actual human embryo by cloning several human embryos, helping to eliminate the need for new embryos. Hwang claimed he had successfully cloned 30 human embryos, claims that have now been shown to be lies. Unfortunately, the use and study of embryonic stem cells are currently clouded by ethical controversy. Adult stem cells offer a unique alternative in that they may be isolated, studied, or manipulated without harming the donor. Currently, several obstacles for use of adult stem cells as therapy exist. First, the ability to identify most adult stem cells is impeded by lack of stem cell markers. Second, in vitro systems for manipulating adult stem cell populations are often not well defined. Finally, our understanding of how adult stem cells are regulated within their niche is in its infancy.
FUTURE PERSPECTIVES OF STEM CELL RESEARCH:
Low blood supply: Now the method to produce large numbers of Red blood cells has been developed. In this method precursor Red blood cells, called hematopoietic stem cells are grown together with stromal cells, creating an environment that mimic the conditions of bone marrow, the natural site of red blood cell growth. Erythropoietin, a growth factor, is added coaxing the stem cells to complete terminal differentiation to red blood cells.
Further research into this technique will have potential benefits to gene therapy& blood transfusion. Baldness: Hair follicles also contain stem cells, and some researchers predict research on these follicle. Stem cell may lead to successes in treating baldness through "hair multi-placation" and known as "hair cloning" as early 2011. This treatment is expected to work through taking stem cells from existing follicles, multiplying them in cultures, and implanting the new follicle cells which have shrunk during the ageing process, which in turn respond to these signals by regenerating and once again making healthy air 17 . Missing teeth: The work on tooth generation has reached to a stage that it will be available to the general population in that decade. In theory, stem cells taken from the patient could be coaxed in the lab into turning into a tooth bud which, when implanted in the gums, will give rise to a new tooth, which would be expected to take two months to grow. It will fuse with jaw bones and release chemicals that encourage nerve and blood vessels to connect with it. In people who suffer from type I diabetes, the cells of the pancreas that normally produce insulin are destroyed by the patient's own immune system. New studies indicate that it may be possible to direct the differentiation of human embryonic stem cells in the cell culture to form insulin-producing cells that eventually could be used in transplantation therapy for diabetics.
ETHICAL CONCERNS IN STEM CELL RESEARCH:
In the case of embryonic stem cell research, the end that scientists hope to achieve is the relief of human suffering. That this is a humanitarian and worthy end is not in dispute. The controversy is about the means, namely, the consumption of donated embryos. More particularly, embryonic stem cell research and therapy would use donated embryos that, by virtue of donor instructions, will never enter a uterus. Is it permissible to use those means to that end? Our task is to decide how we should act toward an embryo, and whether we should recognize, as we do among adults, distinctions between embryos of various types and in various circumstances. We immediately encounter the question of what beings we should classify as "persons" for purposes of the duty not to kill persons. For one who concludes that we are not obliged to refrain from using embryos that will never enter a womb, embryonic stem cell research is a case of fostering a worthy end by using only nonpersons as means.
CONCLUSION:
Stem cells pose a bright future for the therapeutic world by promising treatment options for the diseases which are considered as noncurable now a days. However, because of significant peri and post-transplant morbidity and mortality further research and trials are required to refine and optimize conditioning regimens and modalities of supportive care. By virtue of funding of stem cell research, we hope to see new horizon of therapeutics in the form of organ development and replacement of lost tissue such as hairs, tooth, retina and cochlear cells.
